Artificial intelligence-based detection of FGFR3 mutational status directly from routine histology in bladder cancer: A possible preselection for molecular testing?. Eur. Urol. Focus, (8)2:472--479, Elsevier BV, March 2022. [PUMA: Artificial intelligence; learning; therapy for Deep mutations; Bladder cancer; Molecular fibroblast receptor testing growth factor FGFR3]
Integration of mathematical model predictions into routine workflows to support clinical decision making in haematology. BMC Med. Inform. Decis. Mak., (20)1:28, February 2020. [PUMA: decision-making; workflow; Haematology; Support Mathematical therapy Clinical Data Routine treatment management; simulation; modelling; system optimization; Individual Computer planning; Model-based]
Modeling and processing up-to-dateness of patient information in probabilistic therapy decision support. Artif. Intell. Med., (104)101842:101842, Elsevier BV, April 2020. [PUMA: Therapy decision modules; Decision neck delay; Arden and logic system; Medical model syntax; oncology; support Head]